Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Z Best Place to Talk Stocks -- Ignore unavailable to you. Want to Upgrade?

To: John Carragher who wrote (52353)	11/3/2004 1:11:18 PM
From: E.J. Neitz Jr	Read Replies (1) \| Respond to of 53068

John, the large biotech companies are where the future is. Most of the old line pharma companies will, over the next few years be on an acquisition hunt. I suspect there will be a lot of consolidation we will see. In any event, while a Bush win is positive for the industry, it doesn't do anything for the slow growth of the old line companies that are facing patent expiration which brings on generic competition and does little for modest pipeline realities. Buying Amgen is probably a good approch along with a well managed Generic company. Teva Pharmacuticals is one of the best and at a good price point now.